Predictors of mortality in skin and soft-tissue infections caused by vibrio vulnificus

World Journal of Surgery

Volumn 34, Issue 7, 2010, Pages 1669-1675

  Kuo Chou, Tsai Nung ^a,c   Chao, Wai Nang ^b   Yang, Cheng ^b   Wong, Ruey Hong ^a   Ueng, Kwo Chang ^a,d   Chen, Shiuan Chih ^a,d  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b CHI MEI MEDICAL CENTER   (Taiwan)

^c Yuan Lin Kuo Hospital   (Taiwan)

^d CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

ADULT; AGED; ARTICLE; BACTERIAL SKIN DISEASE; COMORBIDITY; DIABETES MELLITUS; FASCIA; FEMALE; HUMAN; LEUKOCYTOSIS; LIVER DISEASE; MALE; MICROBIOLOGY; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; NECROTIZING FASCIITIS; RETROSPECTIVE STUDY; SEPTIC SHOCK; SOFT TISSUE INFECTION; VIBRIO VULNIFICUS; VIBRIOSIS;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; COMORBIDITY; DIABETES MELLITUS; FASCIA; FASCIITIS, NECROTIZING; FEMALE; HUMANS; LEUKOCYTOSIS; LIVER DISEASES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDIES; SHOCK, SEPTIC; SKIN DISEASES, BACTERIAL; SOFT TISSUE INFECTIONS; VIBRIO INFECTIONS; VIBRIO VULNIFICUS;

EID: 77955471056     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-010-0455-y     Document Type: Article

References (35)

1. DG Hollis RE Weaver CN Baker, et al. 1976 Halophilic Vibrio species isolated from blood cultures J Clin Microbiol 3 425 431 1:STN:280: DyaE287mslyksA%3D%3D 1262454
2. KC Klontz S Lieb M Schreiber, et al. 1988 Syndromes of Vibrio vulnificus infections. Clinical and epidemiologic features in Florida cases, 1981-1987 Ann Intern Med 109 318 323 1:STN:280:DyaL1c3otVSnsQ%3D%3D 3260760
3. YC Chuang CY Yuan CY Liu, et al. 1992 Vibrio vulnificus infection in Taiwan: report of 28 cases and review of clinical manifestations and treatment Clin Infect Dis 15 271 276 1:STN:280:DyaK38zpt12msw%3D%3D 1520762
4. RJ Howard NT Bennett 1993 Infections caused by halophilic marine Vibrio bacteria Ann Surg 217 525 530 10.1097/00000658-199305010-00013 1:STN:280:DyaK3s3ls1KntA%3D%3D 8489315
5. WG Hlady KC Klontz 1996 The epidemiology of Vibrio infections in Florida, 1981-1993 J Infect Dis 173 1176 1183 1:STN:280:DyaK283gvVyktw%3D%3D 8627070
6. PR Hsueh CY Lin HJ Tang, et al. 2004 Vibrio vulnificus in Taiwan Emerg Infect Dis 10 1363 1368 15496235
7. JW Liu IK Lee HJ Tang, et al. 2006 Prognostic factors and antibiotics in Vibrio vulnificus septicemia Arch Intern Med 166 2117 2123 10.1001/archinte.166. 19.2117 17060542 (Pubitemid 44631400)
8. PH Chung SK Chuang T Tsang, et al. 2006 Cutaneous injury and Vibrio vulnificus infection Emerg Infect Dis 12 1302 1303 1:STN:280: DC%2BD28rkslWjuw%3D%3D 16972360
9. Y Inoue T Ono T Matsui, et al. 2008 Epidemiological survey of Vibrio vulnificus infection in Japan between 1999 and 2003 J Dermatol 35 129 139 10.1111/j.1346-8138.2008.00432.x 18346255 (Pubitemid 351421272)
10. PA Blake MH Merson RE Weaver, et al. 1979 Disease caused by a marine Vibrio. Clinical characteristics and epidemiology N Engl J Med 300 1 5 1:STN:280:DyaE1M%2FltlWlsA%3D%3D 758155
11. JM Johnston SF Becker LM McFarland 1985 Vibrio vulnificus. Man and the sea JAMA 253 2850 2853 10.1001/jama.253.19.2850 1:STN:280:DyaL2M7osFOrsQ%3D%3D 3989959 (Pubitemid 15033082)
12. RJ Howard S Lieb 1988 Soft-tissue infections caused by halophilic marine Vibrios Arch Surg 123 245 249 1:STN:280:DyaL1c7jtlensw%3D%3D 3341906
13. AD Penman DC Lanier Jr WT Avara III, et al. 1995 Vibrio vulnificus wound infections from the Mississippi Gulf coastal waters: June to August 1993 South Med J 88 531 533 1:STN:280:DyaK2M3ltVSntg%3D%3D 7732441
14. KD Halow RC Harner LJ Fontenelle 1996 Primary skin infections secondary to Vibrio vulnificus: the role of operative intervention J Am Coll Surg 183 329 334 1:STN:280:DyaK2s%2FgtVWiug%3D%3D 8843261
15. YH Tsai RW Hsu TJ Huang, et al. 2007 Necrotizing soft-tissue infections and sepsis caused by Vibrio vulnificus compared with those caused by Aeromonas species J Bone Joint Surg Am 89 631 636 10.2106/JBJS.F.00580 17332113 (Pubitemid 46365364)
16. MM Levy MP Fink JC Marshall, et al. 2003 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference Intensive Care Med 29 530 538 12664219
17. JY Fagon J Chastre A Novara, et al. 1993 Characterization of intensive care unit patients using a model based on the presence or absence of organ dysfunctions and/or infection: the ODIN model Intensive Care Med 19 137 144 10.1007/BF01720528 1:STN:280:DyaK3szgtFaltQ%3D%3D 8315120
18. Abbott SL, Janda JM, Johnson JA (2007) Vibrio and related organisms. In: Murray PR, Baron EJ, Jorgensen JH et al (eds) Manual of clinical microbiology, vol I, 9th edn. ASM Press, Washington, pp 723-733
19. CR Mehta NR Patel 1995 Exact logistic regression: theory and examples Stat Med 14 2143 2160 10.1002/sim.4780141908 1:STN:280:DyaK287hvVSqsw%3D%3D 8552893
20. SD Park HS Shon NJ Joh 1991 Vibrio vulnificus septicemia in Korea: clinical and epidemiologic findings in seventy patients J Am Acad Dermatol 24 397 403 10.1016/0190-9622(91)70059-B 1:STN:280:DyaK3M3os1Cmsg%3D%3D 2061435
21. MJ Schultz DP Olszyna E de Jonge, et al. 2000 Reduced ex vivo chemokine production by polymorphonuclear cells after in vivo exposure of normal humans to endotoxin J Infect Dis 182 1264 1267 10.1086/315840 1:CAS:528: DC%2BD3cXntlygs7c%3D 10979931
22. D Annane E Bellissant JM Cavaillon 2005 Septic shock Lancet 365 63 78 10.1016/S0140-6736(04)17667-8 1:CAS:528:DC%2BD2MXhvF2gsA%3D%3D 15639681 (Pubitemid 40082148)
23. LI Hor TT Chang ST Wang 1999 Survival of Vibrio vulnificus in whole blood from patients with chronic liver diseases: association with phagocytosis by neutrophils and serum ferritin levels J Infect Dis 179 275 278 10.1086/314554 1:STN:280:DyaK1M%2FlvFyrsQ%3D%3D 9841854 (Pubitemid 29028370)
24. SH Shin DH Shin PY Ryu, et al. 2002 Proinflammatory cytokine profile in Vibrio vulnificus septicemic patients' sera FEMS Immunol Med Microbiol 33 133 138 10.1111/j.1574-695X.2002.tb00582.x 1:CAS:528:DC%2BD38XktFygsrk%3D 12052568
25. JL Powell KA Strauss C Wiley, et al. 2003 Inflammatory cytokine response to Vibrio vulnificus elicited by peripheral blood mononuclear cells from chronic alcohol users is associated with biomarkers of cellular oxidative stress Infect Immun 71 4212 4216 10.1128/IAI.71.7.4212-4216.2003 1:CAS:528: DC%2BD3sXms1Wis7w%3D 12819121 (Pubitemid 36753759)
26. HR Kim HW Rho MH Jeong, et al. 1993 Hemolytic mechanism of cytolysin produced from Vibrio vulnificus Life Sci 53 571 577 10.1016/0024-3205(93)90714-E 1:CAS:528:DyaK3sXlsFeksbY%3D 8350671 (Pubitemid 223040593)
27. EG Biosca C Amaro 1996 Toxic and enzymatic activities of Vibrio vulnificus biotype 2 with respect to host specificity Appl Environ Microbiol 62 2331 2337 1:CAS:528:DyaK28XjvFGnt7c%3D 8779570
28. SR Chiang YC Chuang 2003 Vibrio vulnificus infection: clinical manifestations, pathogenesis, and antimicrobial therapy J Microbiol Immunol Infect 36 81 88 12886957
29. MRE de Araujo C Aquino E Scaramal, et al. 2007 Vibrio vulnificus infection in São Paulo, Brazil: case report and literature review Braz J Infect Dis 11 302 305 17625784
30. JH Bowdre JH Hull DM Cocchetto 1983 Antibiotic efficacy against Vibrio vulnificus in the mouse: superiority of tetracycline J Pharmacol Exp Ther 225 595 598 1:CAS:528:DyaL3sXks1eqs7w%3D 6864521
31. JG Morris Jr J Tenney 1985 Antibiotic therapy for Vibrio vulnificus infection JAMA 253 1121 1122 10.1001/jama.253.8.1121 3968842 (Pubitemid 15103819)
32. PR Hsueh JC Chang SC Chang, et al. 1995 In vitro antimicrobial susceptibility of Vibrio vulnificus isolated in Taiwan Eur J Clin Microbiol Infect Dis 14 151 153 10.1007/BF02111880 1:STN:280:DyaK2M3nvVantg%3D%3D 7758487
33. YC Chuang JW Liu WC Ko, et al. 1997 In vitro synergism between cefotaxime and minocycline against Vibrio vulnificus Antimicrob Agents Chemother 41 2214 2217 1:CAS:528:DyaK2sXms1Sns7s%3D 9333050
34. HJ Tang MC Chang WC Ko, et al. 2002 In vitro and in vivo activities of newer fluoroquinolones against Vibrio vulnificus Antimicrob Agents Chemother 46 3580 3584 10.1128/AAC.46.11.3580-3584.2002 1:CAS:528:DC%2BD38Xot1ykurg%3D 12384368 (Pubitemid 35192929)
35. YC Chuang WC Ko ST Wang, et al. 1998 Minocycline and cefotaxime in the treatment of experimental murine Vibrio vulnificus infection Antimicrob Agents Chemother 42 1319 1322 1:STN:280:DyaK1c3oslGlsQ%3D%3D 9624467